Lindenwold Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.87M | Buy |
15,487
+389
| +3% | +$72.2K | 1.49% | 19 |
|
|
2025
Q1 | $3.16M | Sell |
15,098
-314
| -2% | -$65.8K | 1.76% | 17 |
|
|
2024
Q4 | $2.74M | Sell |
15,412
-328
| -2% | -$58.3K | 1.46% | 20 |
|
|
2024
Q3 | $3.11M | Buy |
15,740
+10
| +0.1% | +$1.98K | 1.57% | 18 |
|
|
2024
Q2 | $2.7M | Sell |
15,730
-57
| -0.4% | -$9.78K | 1.44% | 18 |
|
|
2024
Q1 | $2.87M | Sell |
15,787
-301
| -2% | -$54.8K | 1.54% | 19 |
|
|
2023
Q4 | $2.49M | Sell |
16,088
-52
| -0.3% | -$8.06K | 1.42% | 17 |
|
|
2023
Q3 | $2.41M | Sell |
16,140
-184
| -1% | -$27.4K | 1.5% | 17 |
|
|
2023
Q2 | $2.2M | Sell |
16,324
-2,362
| -13% | -$318K | 1.35% | 21 |
|
|
2023
Q1 | $2.98M | Buy |
18,686
+375
| +2% | +$59.8K | 1.85% | 12 |
|
|
2022
Q4 | $2.96M | Buy |
18,311
+227
| +1% | +$36.7K | 1.98% | 10 |
|
|
2022
Q3 | $2.43M | Buy |
18,084
+190
| +1% | +$25.5K | 1.8% | 13 |
|
|
2022
Q2 | $2.74M | Buy |
17,894
+193
| +1% | +$29.6K | 1.95% | 10 |
|
|
2022
Q1 | $2.87M | Buy |
17,701
+136
| +0.8% | +$22.1K | 1.76% | 12 |
|
|
2021
Q4 | $2.38M | Buy |
+17,565
| New | +$2.38M | 1.39% | 22 |
|